LNP formulations produce strong immune responses, data shows
Drug Discovery World
FEBRUARY 15, 2024
The strengths of etherna’s lipid based nanoparticle (LNP) platform have been showcased in a peer-reviewed paper in Advanced Functional Materials. etherna’s Vice President, Technology & Innovation, Stefaan De Koker described the paper as a “landmark” for the company and its technology.
Let's personalize your content